There was no improvement in overall survival (OS) with pirtobrutinib, but follow-up was limited, and the OS analysis was confounded by crossover from the investigator’s choice arm to the pirtobrutinib ...
Absolutely. Do they make sense for most drivers? Probably not. But that’s exactly why they’re so desirable. In a world full of cookie-cutter crossovers, these sedans stand out as unapologetic ...